Mekonos
Alameda
About Mekonos
Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip. Mekonos is a Silicon Valley Venture-backed technology company ’ creating a proprietary cell-engineering platform based on scalable silicon technology for our partners engaged in drug discovery and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2021)
- Website: mekonos.com
Industries & Categories
Biotechnology, Life Science, Nanotechnology, Robotics, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/mekonos-26523 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.